Fanglei Zhuang is an accomplished Sr. Director at Exact Sciences, where responsibilities include leading the development of innovative cancer detection technologies utilizing next-generation sequencing (NGS). With a proven track record in the biotech industry, Zhuang previously served as Director at Exact Sciences, achieving a 50% cost reduction in testing configurations and enhancing early-stage cancer sensitivity by 28% through a new mutation detection assay. Experience also includes roles as Associate Director at both Exact Sciences and Skinap Therapeutics, focusing on biomarker assay development and preclinical drug development, respectively. Zhuang's earlier career encompassed leadership as Group Leader at Bio-Rad Laboratories and Senior Scientist at GnuBIO, Inc., contributing to advancements in NGS platforms and cancer diagnostics. Zhuang holds a PhD in Cellular and Molecular Biology from The University of Texas at Austin and a B.S. in Biology from Zhejiang University.
This person is not in any teams
This person is not in any offices